CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the effects of alpha emitter radiation therapy on cancer cells, aiming to improve treatment outcomes while minimizing side effects. It explores the potential of combining this therapy with radiofrequency fields to enhance efficacy and reduce toxicity in cancer treatment.
The Effect of Alpha emitters and Radiofrequency Fields on cancer cells in culture.Alpha emitter radiation therapy involves the use of radionuclides that decay, emitting an alpha particle that kills the cancer cells.
Radiopharmaceuticals that emit low levels of alpha particle radiation are used to treat different cancers.
Compared to other treatment options such as external beam radiation and chemotherapy, alpha emitter radiation therapy results in better treatment outcome.
There are however side…
VILNIAUS UNIVERSITETAS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Norway, Oslo
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
